Hoth Therapeutics, Inc. — All Filings
319 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
3
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
ARS
CERT
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-8
SC 13G
SC 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | QUARTERLY REPORT | 0001213900-24-042906 | May 14, 2024 | Mar 31, 2024 |
| 424B3 | PROSPECTUS | 0001213900-24-034927 | Apr 22, 2024 | — |
| EFFECT | — | 9999999995-24-001054 | Apr 19, 2024 | — |
| CORRESP | — | 0001213900-24-034103 | Apr 18, 2024 | — |
| UPLOAD | — | 0000000000-24-004181 | Apr 17, 2024 | — |
| S-1 | REGISTRATION STATEMENT | 0001213900-24-032207 | Apr 11, 2024 | — |
| 10-K | ANNUAL REPORT | 0001213900-24-027213 | Mar 28, 2024 | Dec 31, 2023 |
| 8-K | CURRENT REPORT | 0001213900-24-026868 | Mar 28, 2024 | Mar 27, 2024 |
| 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-24-026878 | Mar 28, 2024 | — |
| SC 13G/A | — | 0001172661-24-001269 | Feb 14, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-002248 | Jan 9, 2024 | Jan 8, 2024 |
| 4 | — | 0001213900-24-001959 | Jan 8, 2024 | Jan 5, 2024 |
| 4 | — | 0001213900-24-001960 | Jan 8, 2024 | Jan 5, 2024 |
| 4 | — | 0001213900-24-001955 | Jan 8, 2024 | Jan 5, 2024 |
| 4 | — | 0001213900-24-001958 | Jan 8, 2024 | Jan 5, 2024 |
| 4 | OWNERSHIP DOCUMENT | 0001213900-24-001954 | Jan 8, 2024 | Jan 5, 2024 |
| 10-Q | QUARTERLY REPORT | 0001213900-23-086133 | Nov 13, 2023 | Sep 30, 2023 |
| 8-K | CURRENT REPORT | 0001013762-23-002005 | Oct 5, 2023 | Oct 4, 2023 |
| 8-K | CURRENT REPORT | 0001213900-23-077030 | Sep 15, 2023 | Sep 13, 2023 |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-23-076751 | Sep 14, 2023 | — |
| 8-K | CURRENT REPORT | 0001213900-23-069494 | Aug 21, 2023 | Aug 18, 2023 |
| S-8 | REGISTRATION STATEMENT | 0001213900-23-069462 | Aug 21, 2023 | — |
| 8-K | CURRENT REPORT | 0001213900-23-068330 | Aug 17, 2023 | Aug 16, 2023 |
| 10-Q | QUARTERLY REPORT | 0001213900-23-066246 | Aug 11, 2023 | Jun 30, 2023 |
| 4 | — | 0001213900-23-057861 | Jul 18, 2023 | Jul 17, 2023 |
| 4 | — | 0001213900-23-057862 | Jul 18, 2023 | Jul 17, 2023 |
| 4 | — | 0001213900-23-057864 | Jul 18, 2023 | Jul 17, 2023 |
| 4 | — | 0001213900-23-057859 | Jul 18, 2023 | Jul 17, 2023 |
| 4 | — | 0001213900-23-057860 | Jul 18, 2023 | Jul 17, 2023 |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-23-052148 | Jun 27, 2023 | — |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-23-052141 | Jun 27, 2023 | Aug 18, 2023 |
| EFFECT | — | 9999999995-23-001783 | Jun 16, 2023 | — |
| CORRESP | — | 0001213900-23-049254 | Jun 15, 2023 | — |
| UPLOAD | — | 0000000000-23-006491 | Jun 15, 2023 | — |
| S-3 | REGISTRATION STATEMENT | 0001213900-23-048616 | Jun 13, 2023 | — |
| 8-K | CURRENT REPORT | 0001213900-23-046791 | Jun 6, 2023 | May 19, 2023 |
| 10-Q | QUARTERLY REPORT | 0001213900-23-039789 | May 15, 2023 | Mar 31, 2023 |
| 10-K | ANNUAL REPORT | 0001213900-23-025455 | Mar 31, 2023 | Dec 31, 2022 |
| 8-K | CURRENT REPORT | 0001213900-23-015045 | Feb 28, 2023 | Feb 24, 2023 |
| SC 13G | — | 0001172661-23-001116 | Feb 14, 2023 | — |
| SC 13G/A | AMENDMENT NO. 2 TO SCHEDULE 13G | 0001213900-23-009119 | Feb 8, 2023 | — |
| 424B3 | PROSPECTUS | 0001213900-23-005327 | Jan 26, 2023 | — |
| EFFECT | — | 9999999995-23-000183 | Jan 25, 2023 | — |
| CORRESP | — | 0001213900-23-004444 | Jan 23, 2023 | — |
| UPLOAD | — | 0000000000-23-000707 | Jan 23, 2023 | — |
| S-3 | REGISTRATION STATEMENT | 0001213900-23-002795 | Jan 13, 2023 | — |
| UPLOAD | — | 0000000000-23-000074 | Jan 4, 2023 | — |
| D | — | 0001213900-23-000912 | Jan 4, 2023 | — |
| CORRESP | — | 0001213900-23-000426 | Jan 3, 2023 | — |
| 8-K | CURRENT REPORT | 0001213900-22-084039 | Dec 30, 2022 | Dec 29, 2022 |